Page last updated: 2024-10-21

3-methoxytyramine and Autistic Disorder

3-methoxytyramine has been researched along with Autistic Disorder in 2 studies

3-methoxytyramine: RN given refers to parent cpd
3-methoxytyramine : A monomethoxybenzene that is dopamine in which the hydroxy group at position 3 is replaced by a methoxy group. It is a metabolite of the neurotransmitter dopamine and considered a potential biomarker of pheochromocytomas and paragangliomas.

Autistic Disorder: A disorder beginning in childhood. It is marked by the presence of markedly abnormal or impaired development in social interaction and communication and a markedly restricted repertoire of activity and interest. Manifestations of the disorder vary greatly depending on the developmental level and chronological age of the individual. (DSM-V)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Martineau, J2
Barthélémy, C2
Jouve, J2
Muh, JP1
Lelord, G2
Garreau, B1

Other Studies

2 other studies available for 3-methoxytyramine and Autistic Disorder

ArticleYear
Monoamines (serotonin and catecholamines) and their derivatives in infantile autism: age-related changes and drug effects.
    Developmental medicine and child neurology, 1992, Volume: 34, Issue:7

    Topics: 3,4-Dihydroxyphenylacetic Acid; Age Factors; Autistic Disorder; Catecholamines; Child; Child Develop

1992
[Development in the metabolism of dopamine and its derivatives. Application to gross development disorders].
    Neurophysiologie clinique = Clinical neurophysiology, 1992, Volume: 22, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Analysis of Variance; Autistic Disorder; Child; Child, Presch

1992
chemdatabank.com